ESTIMATING HOSPITAL COSTS FOR BUPIVACAINE LIPOSOMAL INJECTABLE SUSPENSION IN MEDICARE PATIENTS UNDERGOING TOTAL KNEE ARTHROPLASTY USING PREMIER CHARGEMASTER DATA
May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.1133
https://www.valueinhealthjournal.com/article/S1098-3015(16)01201-8/fulltext
Section Title :
Muscular-Skeletal Disorders - Cost Studies
Section Order :
807
First Page :
A230
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01201-8&doi=10.1016/j.jval.2016.03.1133